(Q26859216)

language of work or name

1 reference

November 2012

1 reference

published in

Liver Transplantation

1 reference

volume

18

1 reference

issue

11

1 reference

page(s)

1277-89

1 reference

Solid organ allograft survival improvement in the United States: the long-term does not mirror the dramatic short-term success.

cites work

1 reference

Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study

21 January 2018

1 reference

Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation

21 January 2018

1 reference

Risk of malignant neoplasms after liver transplantation: a population-based study

21 January 2018

1 reference

Spectrum of cancer risk among US solid organ transplant recipients

21 January 2018

1 reference

Comparison of the incidence of malignancy in recipients of different types of organ: a UK Registry audit.

21 January 2018

1 reference

Posttransplant lymphoproliferative disease in pediatric liver transplantation. Interplay between primary Epstein-Barr virus infection and immunosuppression

21 January 2018

1 reference

Autopsy pathology of pediatric posttransplant lymphoproliferative disorder.

21 January 2018

1 reference

Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center.

21 January 2018

1 reference

Development of lymphoproliferative disease after liver transplantation

21 January 2018

1 reference

An integrated safety profile analysis of belatacept in kidney transplant recipients

21 January 2018

1 reference

Epidemiology of pretransplant EBV and CMV serostatus in relation to posttransplant non-Hodgkin lymphoma

21 January 2018

1 reference

Epstein-Barr virus-associated B-cell lymphomas: pathogenesis and clinical outcomes

21 January 2018

1 reference

Epstein-Barr virus-negative post-transplant lymphoproliferative disorders: a distinct entity?

21 January 2018

1 reference

Epstein-Barr virus-negative lymphoproliferate disorders in long-term survivors after heart, kidney, and liver transplant

21 January 2018

1 reference

Posttransplantation lymphoproliferative disorders in solid organ recipients are predominantly aggressive tumors of host origin

21 January 2018

1 reference

Epstein-Barr virus infection in transplant recipients: Summary of a workshop on surveillance, prevention and treatment

21 January 2018

1 reference

Lymphoproliferative disorders in renal transplant patients in Japan.

21 January 2018

1 reference

Post-transplant lymphoproliferative disorder after pediatric liver transplantation: characteristics and outcome

21 January 2018

1 reference

Diagnosis of post-transplant lymphoproliferative disorder in solid organ transplant recipients - BCSH and BTS Guidelines.

21 January 2018

1 reference

Identification of prognostic factors in 61 patients with posttransplantation lymphoproliferative disorders.

21 January 2018

1 reference

Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: outcomes and prognostic factors in the modern era.

21 January 2018

1 reference

Plasmablastic posttransplant lymphoma: cytogenetic aberrations and lack of Epstein-Barr virus association linked with poor outcome in the prospective German Posttransplant Lymphoproliferative Disorder Registry.

21 January 2018

1 reference

Posttransplant lymphoproliferative disorders in liver transplantation: a 20-year experience

21 January 2018

1 reference

Post-transplant lymphoproliferative syndrome in the pediatric liver transplant population

21 January 2018

1 reference

Reduction of immunosuppression as initial therapy for posttransplantation lymphoproliferative disorder(★).

21 January 2018

1 reference

Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patients

21 January 2018

1 reference

Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy

21 January 2018

1 reference

The role of quantitative Epstein-Barr virus polymerase chain reaction and preemptive immunosuppression reduction in pediatric liver transplantation: a preliminary experience

21 January 2018

1 reference

Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting

21 January 2018

1 reference

The role of valacyclovir on Epstein-Barr virus viral loads in pediatric liver transplantation patients

21 January 2018

1 reference

The role of antiviral and immunoglobulin therapy in the prevention of Epstein-Barr virus infection and post-transplant lymphoproliferative disease following solid organ transplantation

21 January 2018

1 reference

Rituximab therapy is effective for posttransplant lymphoproliferative disorders after solid organ transplantation: results of a phase II trial

21 January 2018

1 reference

Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study

21 January 2018

1 reference

Salvage therapy for relapsed posttransplant lymphoproliferative disorders (PTLD) with a second progression of PTLD after Upfront chemotherapy: the role of single-agent rituximab

21 January 2018

1 reference

Tolerability and safety of rituximab (MabThera).

21 January 2018

1 reference

Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial.

21 January 2018

1 reference

Chemotherapy for posttransplant lymphoproliferative disorder: the Israel Penn International Transplant Tumor Registry experience

21 January 2018

1 reference

Long-term probability of and mortality from de novo malignancy after liver transplantation

21 January 2018

1 reference

Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study

21 January 2018

1 reference

Risk factors associated with the development of skin cancer after liver transplantation

21 January 2018

1 reference

Nonmelanoma skin cancer after liver transplantation. Study of risk factors.

21 January 2018

1 reference

Skin cancers after organ transplantation

21 January 2018

1 reference

Preventable exposures associated with human cancers

21 January 2018

1 reference

Molecular mechanisms of alcohol-mediated carcinogenesis

21 January 2018

1 reference

Colorectal and anal neoplasms following liver transplantation

21 January 2018

1 reference

Increased risk of early colorectal neoplasms after hepatic transplant in patients with inflammatory bowel disease

21 January 2018

1 reference

Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation.

21 January 2018

1 reference

Human herpesvirus 8-associated neoplasms: the roles of viral replication and antiviral treatment.

21 January 2018

1 reference

Surveillance of human papilloma virus infection and cervical cancer in kidney transplant recipients: preliminary data

21 January 2018

1 reference

High hepatitis B virus DNA level in serum before liver transplantation increases the risk of hepatocellular carcinoma recurrence

21 January 2018

1 reference

De novo hepatocellular carcinoma in a liver graft with sustained hepatitis C virus clearance after living donor liver transplantation.

21 January 2018

1 reference

Cancer risk following organ transplantation: a nationwide cohort study in Sweden

21 January 2018

1 reference

Incidence and management of colorectal cancer in liver transplant recipients

21 January 2018

1 reference

Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis

21 January 2018

1 reference

Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease.

21 January 2018

1 reference

Characteristics of thoracic malignancies that occur after solid-organ transplantation

21 January 2018

1 reference

Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data

21 January 2018

1 reference

Human papilloma virus infection and cervical intraepithelial neoplasia in transplanted patients

21 January 2018

1 reference

Organ transplant recipients and skin cancer: assessment of risk factors with focus on sun exposure

21 January 2018

1 reference

Screening of de novo tumors after liver transplantation

21 January 2018

1 reference

Reduction of immunosuppression for transplant-associated skin cancer: rationale and evidence of efficacy

21 January 2018

1 reference

Successful treatment of post-transplant Kaposi's sarcoma by reduction of immunosuppression.

21 January 2018

1 reference

Immune functional assay for immunosuppressive management in post-transplant malignancy

21 January 2018

1 reference

Calcineurin inhibitors activate the proto-oncogene Ras and promote protumorigenic signals in renal cancer cells

21 January 2018

1 reference

Azathioprine and UVA light generate mutagenic oxidative DNA damage

21 January 2018

1 reference

Prospective registry-based observational cohort study of the long-term risk of malignancies in renal transplant patients treated with mycophenolate mofetil

21 January 2018

1 reference

Mycophenolate mofetil and risk of developing malignancy after orthotopic heart transplantation: analysis of the transplant registry of the International Society for Heart and Lung Transplantation.

21 January 2018

1 reference

Combined introduction of anti-IL2 receptor antibodies, mycophenolic acid and tacrolimus: effect on malignancies after renal transplantation in a single-centre retrospective cohort study.

21 January 2018

1 reference

Dissociation of depletional induction and posttransplant lymphoproliferative disease in kidney recipients treated with alemtuzumab.

21 January 2018

1 reference

Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens

21 January 2018

1 reference

Increased incidence of early de novo cancer in liver graft recipients treated with cyclosporine: an association with C2 monitoring and recipient age.

21 January 2018

1 reference

Targeting the mammalian target of rapamycin (mTOR): a new approach to treating cancer

21 January 2018

1 reference

The mTOR inhibitor RAD001 sensitizes tumor cells to DNA-damaged induced apoptosis through inhibition of p21 translation.

21 January 2018

1 reference

Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer

21 January 2018

1 reference

Emerging roles for mammalian target of rapamycin inhibitors in the treatment of solid tumors and hematological malignancies

21 January 2018

1 reference

Two-year incidence of malignancy in sirolimus-treated renal transplant recipients: results from five multicenter studies

21 January 2018

1 reference

Lower malignancy rates in renal allograft recipients converted to sirolimus-based, calcineurin inhibitor-free immunotherapy: 24-month results from the CONVERT trial

21 January 2018

1 reference

The ORION study: comparison of two sirolimus-based regimens versus tacrolimus and mycophenolate mofetil in renal allograft recipients

21 January 2018

1 reference

Randomized controlled trial of sirolimus for renal transplant recipients at high risk for nonmelanoma skin cancer

21 January 2018

1 reference

Influence of immunosuppressive drugs on the recurrence of hepatocellular carcinoma after liver transplantation: a gap between basic science and clinical evidence

21 January 2018

1 reference

Human herpes virus 8 in solid organ transplantation

21 January 2018

1 reference

Incidence and Clinical Predictors of a Subsequent Nonmelanoma Skin Cancer in Solid Organ Transplant Recipients With a First Nonmelanoma Skin Cancer

21 January 2018

1 reference

Risk factors of lung, head and neck, esophageal, and kidney and urinary tract carcinomas after liver transplantation: The effect of smoking withdrawal

21 January 2018

1 reference